CYLD was originally identified as a tumor suppressor gene that was mutated in familial cylindromatosis, Brooke–Spiegler syndrome and familial tricoepitheliomas44, which are autosomal dominant disorders predisposing to benign tumors of skin appendages. Here, CYLD is linked to neoplasm.